Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/20070
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2017-06-24T08:21:21Z-
dc.date.available2017-06-24T08:21:21Z-
dc.date.issued1983-
dc.identifier.citationMarc, R., & Roland, B. (1983). New drugs for heart failure. Medi-Scope, 4, 10-11.en_GB
dc.identifier.urihttps://www.um.edu.mt/library/oar//handle/123456789/20070-
dc.description.abstractAdaptation or compensatory mechanisms generally conceal the clinical signs at the beginning of heart failure (Starling's law). When these mechanisms are exceeded, heart failure may be objectivated: there is an increase in the left ventricular diastolic pressure, and if failure is severe, cardiac output decreases. These haemodynamic changes affect preload and afterload and are responsible for the clinical signs of heart failure.en_GB
dc.language.isoenen_GB
dc.publisherUniversity of Malta Medical Schoolen_GB
dc.rightsinfo:eu-repo/semantics/openAccessen_GB
dc.subjectHeart failure -- Treatmenten_GB
dc.subjectHeart failure -- Etiologyen_GB
dc.subjectCongestive heart failureen_GB
dc.subjectHeart failure -- Chemotherapyen_GB
dc.titleNew drugs for heart failureen_GB
dc.typearticleen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.description.reviewedN/Aen_GB
dc.contributor.creatorRoland, Bernard-
dc.contributor.creatorMarc, Renard-
Appears in Collections:Medi-Scope, Issue 4
Medi-Scope, Issue 4

Files in This Item:
File Description SizeFormat 
Mediscope 04 - A2.pdf158.85 kBAdobe PDFView/Open


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.